Strategic Partnerships Molteni Farmaceutici has active and growing international partnerships in cannabis-derived therapies and controlled substances, presenting opportunities to expand co-development, manufacturing, or distribution for EU-GMP products and specialized pain or addiction treatments.

European Expansion With a strong Italian base and an expanding international presence, there are sales opportunities to support market entry, regulatory alignment, and supply chain partnerships for new therapies targeting pain management and substance use disorder on European markets.

Cannabis Therapeutics Recent partnerships with Tilray and OncoZenge indicate validated demand for cannabis-based pain and specialty therapies, suggesting cross-sell of complementary formulations, patient-support programs, and compliant manufacturing services.

Contract Manufacturing Molteni already handles commercial-scale manufacturing for complex products; there is potential to offer expanded contract manufacturing capabilities to other niche therapies, including controlled substances, to diversify and de-risk capacity utilization.

Healthcare Systems Position Molteni as a long-term partner for healthcare systems and institutions by highlighting Made in Italy quality, regulatory compliance, and sustainable care solutions to win multi-year supply agreements and precision delivery contracts for high-value therapies.